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Abstract Copper and iron metabolism have been
known to interact for many years. We have previously
shown, during pregnancy, that copper levels in the
maternal liver rise as a consequence of iron deficiency,
but that levels in the fetal liver decrease. In this paper,
we measure expression of genes involved in copper
metabolism in fetal and postnatal liver, to test whether
alterations can explain this observation. Additionally,
we study the extent to which gene expression changes
in the latter stages of pregnancy and in the perinatal
period. Ctr1 expression levels dropped to term, rising
again thereafter. There was no difference in gene
expression between control and iron deficient animals.
Atox1 expression remained approximately stable until
term, and then there was a rise to a maximum at about
Day 8. Atp7a expression levels remained constant,
except for a brief drop at term. Atp7b levels, in contrast,
decreased from a maximum early in gestation to low
levels in the term and post-natal livers. Ceruloplasmin
expression appeared to be diametrically opposite to
Atp7b. The other two metallochaperones showed the
same pattern of expression as Atox1, with a decrease to
term, a rise at Day 1, or a rise after birth followed by a
brief decrease at about Day 3. None of the genes were
significantly affected by iron deficiency, suggesting
that changes in expression cannot explain the altered
copper levels in the fetal and neonatal liver.
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Introduction
Copper is a micronutrient, essential for normal growth
and development. It is a cofactor for enzymes that
catalyze reactions used in fundamental metabolic
processes, including respiratory oxidation, neurotrans-
mitter synthesis, iron uptake regulation, and connec-
tive tissue formation (Lutsenko et al. 2007). However,
an excess of copper has the potential to be toxic, as the
ions are potent generators of free radicals, which could
lead to oxidative damage of proteins, lipids and nucleic
acids (Lutsenko et al. 2007; Van den Berghe and
Klomp 2010; Velthuis et al. 2009). Consequently,
organisms have developed complex and genetically
regulated control mechanisms for maintaining the
balance between essential and toxic copper levels.
In mammals, copper is absorbed mainly in the
stomach and duodenum and is transported in plasma to
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the liver (Van den Berghe and Klomp 2010), the main
organ responsible for copper homeostasis. The copper
is stored primarily as a copper-metallothionein com-
plex (Bauerly et al. 2005; Czachor et al. 2002; Davis
and Cousins 2000) and is excreted through bile
(Huster et al. 2006; Wijmenga and Klomp 2004).
Copper uptake by hepatocytes is mediated by the
high affinity copper transporter 1 (CTR1) (Kuo et al.
2001, 2006). In the cell the copper is bound to
metallochaperones, and transported to the different
compartments of the cell (O’Halloran and Cizewski
Culotta 2000). Different chaperones deliver the copper
to different enzymes. The copper chaperone of
superoxide dismutase (CCS) partitions copper for
SOD synthesis (Wong et al. 2000; Bertinato et al.
2003; Prohaska et al. 2003). Copper ions bound to
COX 17 chaperone are transported to mitochondria
where they are bound to the subunits of the cyto-
chrome-c oxidase (Nevitt et al. 2012; Kako et al. 2004;
Punter and Glerum 2003). ATOX1 transport copper to
the trans-Golgi network where it is incorporated into
the two Cu-transporting ATPases, ATP7A and ATP7B
proteins (Barry et al. 2010; Pufahl et al. 1997;
Lutsenko et al. 2007, 2008). In hepatocytes, ATP7B
delivers copper to ceruloplasmin, a major form of
copper in serum. It is also the pathway of excretion of
copper into the bile (Huster et al. 2006; La Fontaine
et al. 2001; Wijmenga and Klomp 2004). ATP7A is
not expressed in the adult liver, but in other tissues is
involved in copper excretion and absorption. These
data are summarized in Fig. 1.
Metabolic interactions between the two essential
elements, copper and iron, have been known for many
years (McArdle 1992; McArdle et al. 2008; Gambling
et al. 2011). In the early part of the last century it was
shown that copper could facilitate hemoglobin forma-
tion in anemic rats (Hart et al. 1928). More recently, it
has been demonstrated that iron metabolism is criti-
cally dependent on ferroxidases, most of which are
copper enzymes. How iron alters copper metabolism is
not so well understood. We have previously shown
that iron deficiency results in accumulation of copper
in the maternal, but not fetal liver. How this occurs is
not clear but is presumably related to alterations in
gene expression in one of the major organs involved in
iron and copper transfer from mother to fetus. In this
paper, therefore, we examine the effect of iron
deficiency on expression of the genes of copper
metabolism, with a view to identifying the changes
that could explain alterations in copper levels in the
maternal and fetal livers.
Materials and methods
Animals and diets
Ethical approval
All animal experiments were performed in the Biore-
sources Unit of the Rowett Institute of Nutrition and
Health, under licence from the United Kingdom Home
Office in accordance with the UK Animals (Scientific
Procedures) Act, 1986. The study was approved by the
UK Home Office (Project Licence PPL 60/3606) and
the Rowett Institute of Nutrition and Health Ethics
Review Committee (approval ID SA09/03E).
Experimental diets
The experimental diets were based on a dried egg
albumin diet and conformed to American Institute of
Nutrition guidelines for laboratory animals (Williams
and Mills 1970). FeSO4 was added to achieve levels of
added iron of 50 (control diet) and 7.5 (iron deficient
diet) mg kg-1. Dietary ingredients were purchased
Fig. 1 The model used to study gene expression in this paper.
Copper is taken up across the cell membrane, binds to the
relevant chaperone and is incorporated into the target protein.
More information is given in the text in the relevant section
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from Mayjex Ltd (Chalfont-St Peter, UK), BDH
Chemicals (Poole, UK) or Sigma (Poole, UK). Diet
formulations have all previously been used (Gambling
et al. 2003a).
Experimental animals and tissue collection
Experiments were performed using weanling female
rats of the Rowett Hooded Lister strain. Animals were
housed in cages under constant conditions (tempera-
ture, humidity, 12L:12D illumination photoperiod).
Female weanling rats were fed control diet for
2 weeks, before being randomised into two groups.
The first group remained on the control diet through-
out the experiment, including pregnancy, whilst the
scond were given the iron deficient diet for 4 weeks
prior to mating. The rats were mated with males of the
same strain. Mating was confirmed by detection of a
vaginal plug, and this day was denoted as Day 0.5. The
female rats were maintained on the same diet
throughout pregnancy.
At times stated in the results, 8 rats from each
group were killed as described below. At parturition,
blood and tissue samples were taken from 8 dams
and their litters, from birth the control and iron
deficient groups. Following parturition all remaining
dams fed on control diet during pregnancy continued
on this diet. At the same time dams fed on the iron
deficient diet during pregnancy were split into two
groups, half remained on the iron deficient diet,
whilst the diet for the remaining dams was changed
to the control diet. Within 24 h of birth all litters
were culled to 8 pups, with male pups being kept
preferentially. Over the next 10 days, there were 4
time points at which 8 dams and their litters from
each of the now 3 groups, were killed and blood and
tissue samples taken. These time points were 1, 3, 7
and 10 days after birth.
Dams were anesthetized with isoflurane, and
maternal blood samples collected from the heart.
The dams were then killed by cervical dislocation.
Tissue samples were also taken from the dam. The
fetuses or neonates were weighed, and then killed by
decapitation. Blood samples were collected from each
of the neonates, and pooled to provide a representative
litter sample. Organs were weighed and snap frozen in
liquid nitrogen before being stored at -80 C. In order
to obtain representative samples, tissues from the 3
pups closest to the litter median, determined by body
weight, were pooled and ground. These pooled
samples were used for all future analysis.
RNA isolation
Total RNA was prepared from 50 mg of frozen liver
tissue by homogenizing in cold TRI reagent (Helena
Biosciences, Sunderland, UK) according to the man-
ufacturer’s instructions. RNA were precipitated in
isopropanol and dissolved in DNAse, RNASe free
water. Concentration of RNA in samples was mea-
sured in a NanoDropTM 2000c spectrophotometer
(Thermo Scientific) OD 260/280 and purify of RNA
was estimated using OD 260/230. RNA integrity was
determined using Agilent 2100 Bioanalyzer (Agilent
Technologies) according to the manufacturer’s
instructions. To avoid contamination of obtained
RNA with genomic DNA, 1 ug of total RNA samples
were treated with ribonuclease (RNase)-free Dnase 1
Amplification Grade (Invitrogen Ltd, Paisley, UK),
before the reaction of reverse transcription. Reverse
transcription was performed according to the manual
instruction using the Taqman RT Reagent Kit
(Applied Biosystem) from 200 ng of DNAse-treated
RNA.
Real time PCR reaction
Real-time quantitative PCR was performed using the
7700 Real Time PCR system (Applied Biosystem) and
Table 1 Primer list used for real-time quantitative RT-PCR
analysis
Gene Sequence/cat. no
MWG Eurofins
primers made to order
Sequence
Atp7a forward 50-aggcaaatttccagtggatg-30
Atp7a reverse 50-atgaggagcgatccattctg-30
Atp7b forward 50-acatgctaatccccagcagt-30
Atp7b reverse 50-gatgagcacatccatgttgg-30
Quantitect primer assays Cat. no
Atox1 QT01081696
Ctr1 (Slc31a1) QT00175161
Cox17 QT00183827
CCS QT00181286
Cp1 QT00495075
UBQc QT00372596
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the primers specific for analysed gene (Table 1).
Primers for Atp7a and Atp7b genes were designed,
using Primer Express software and were ordered in
MWG Eurofins Company, sequence of primers is
showed in Table 1. Primers for metallochaperones,
Ctr1, ceruloplasmin (Cp) and ubiquitin genes
(Table 1) obtained from Qiagen. Quantification was
performed relative ubiquitin control reaction. To
confirm amplification specificity, the PCR products
from each primer pair were subjected to melting curve
analysis and subsequent agarose gel electrophoresis.
The relative expression of each gene was calculated as
2-DDCT.
Statistical analysis
All data are expressed as mean ± SEM. Comparison
of the relative expression level were made by one-way
ANOVA followed by the NIR Fisher post hoc test.
Student t test was used when comparing data between
control and Fe-deficient rats. Values of p \ 0.05 were
considered statistically significant.
Results
In the liver of both normal and iron deficient rats
expression of the Ctr1 gene decreased from 17.5 to the
21.5 days gestation, then increased postnatally. There
was no significant difference in expression between
control and Fe deficient livers, though there was an
apparent trend (p = 0.07) (Fig. 2). After entry to the
hepatocytes, copper is bound to chaperone proteins.
We measured mRNA levels of Atox1 in control and
iron deficient fetal livers. There were no significant
differences between the two groups at any stage of
gestation or postnatal life (Fig. 3). As with Ctr1, levels
decreased to term. After birth, levels rose in both
control and Fe deficient pups. However, there was a
decrease at Day 3. Currently, we do not have an
explanation for this observation.
ATOX1 protein delivers the copper ions to the
Golgi apparatus, where they bind to the Cu-transport-
ing ATPases, ATP7A and ATP7B. Both Atp7a and 7b
genes were expressed in the fetal liver. Levels dropped
to term, and did not change subsequently for Atp7b
(Fig. 4). In contrast, Atp7a expression rose briefly at
Day 3 (see above for Atox1) thereafter returning to
levels seen at Day 0 (Fig. 5). In adult liver, ATP7A
expression is negligible. However, in the neonates,
expression levels were significantly higher than Atp7b,
Fig. 2 Developmental changes in the expression level of the
Ctr1 gene in the liver of the control and Fe deficient fetus and
neonates. The mRNA level are shown relative to ubiquitin.
Values with different letters differ significantly (p\0.05). Data
are expressed as mean ± SEM
Fig. 3 Expression pattern of the ATOX1 gene in the liver of the
control and Fe deficient rats between 17.5 and 21.5 of gestation
and Day 0 to Day 10 of the postnatal life. The mRNA level is
shown relative to ubiquitin. Values with different letters
differ significantly. Data are expressed as mean ± SEM
Fig. 4 Developmental changes in the expression level of the
Atp7b gene in the liver of the control and Fe deficient fetus and
neonates. The mRNA level is shown relative to ubiquitin.
Values with different letters differ significantly (p \ 0.05)
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implying that the former may play a significant role in
hepatic copper metabolism in the neonate.
The ATP7B Cu-ATPase delivers copper to cerulo-
plasmin, so we determined expression levels of Cp in
the fetal and neonatal liver. Before birth, expression
increased in the fetal liver, dropped to their lowest
levels at Day 3 and thereafter increased (Fig. 6). There
was no difference in mRNA levels between control
and Fe-deficient animals. Further, expression levels of
Cp were not correlated with expression of Atp7b (data
not shown).
Copper bound to CCS is used for SOD1 synthesis.
In both control and iron deficient animals, CCS levels
dropped during pregnancy, rose in the immediate post-
natal period, then fell again at Day 3 (Fig. 7). The
increase in expression after Day 3 was significantly
greater in controls than in animals from iron deficient
dams.
Finally, Cox17 expression was measured. As with
the other chaperones, there was a drop followed by a
rise at birth, thereafter falling back at Day 3 (Fig. 8).
From then, there was a rise until the end of the
experiment at Day 10 post-natal. The difference
between control and Fe-deficient animals was not
significant.
Discussion
Copper and iron are micronutrients essential for
normal fetal development. Both are transferred from
mother to fetus across the placenta (Gambling et al.
2003b; Hardman et al. 2007; McArdle et al. 2003).
The metabolisms of the two elements have been
known to interact for many years (reviewed in Collins
et al. 2010; McArdle 1992; Gambling et al. 2011). Iron
Fig. 5 The Atp7a mRNA profile of the liver of the control and
Fe deficient fetus and neonates. The mRNA level is corrected
relative to ubiquitin. Values with different letters differ
significantly (p \ 0.05)
Fig. 6 Ceruloplasmin mRNA level in the liver through
developmental stages of the control and Fe deficient fetus and
neonates. The mRNA level is shown relative to ubiquitin.
Values with different letters differ significantly (p \ 0.05). Data
are expressed as mean ± SEM
Fig. 7 Relative expression of the CCS gene using ubiquitin as
the endogenous normalization control in the liver of the control
and Fe deficient fetus and neonates. Values with different letters
differ significantly (p \ 0.05). Data are expressed as
mean ± SEM
Fig. 8 Developmental changes in the expression level of the
Cox17 gene in the liver of the control and Fe deficient fetus and
neonates. The mRNA level is shown relative to ubiquitin.
Values with different letters differ significantly (p \ 0.05). Data
are expressed as mean ± SEM
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release from cells is dependent on copper oxidases;
hephaestin in the gut, ceruloplasmin in the liver and
zyklopen in the placenta. Copper deficiency, therefore,
results in accumulation of iron in the liver, and in the
kidney and brain. The effect of iron deficiency on
copper metabolism is not so well studied. We have
shown, as have others (Sherman and Moran 1984;
Sherman and Tissue 1981) that, during pregnancy,
copper levels in the fetal liver decrease in response to
maternal iron deficiency, in contrast to the maternal
liver, where iron deficiency results in an increase in
copper levels (Gambling et al. 2004). How this occurs
is not known. In this paper, we test the hypothesis that
alterations in expression levels of the genes involved
in copper metabolism are involved in the mechanism.
Further, we also examine how gene expression
changes as development proceeds through late gesta-
tion and the early neonatal period.
Terao and Owen (1977) reported that in rats, the
copper concentration in the fetal liver was highest at
day 18 of pregnancy and decreased to day 21. After
birth, copper levels significantly increased up to
postnatal day 7. From then, levels remained high until
about the second week of life, thereafter decreasing to
adult levels by six weeks of age (Terao and Owen
1977). In mammalian cells, copper import is primarily
mediated by CTR1 protein (Ansede et al. 2009; Kim
et al. 2009; Lee et al. 2002; Nose et al. 2006; Van den
Berghe and Klomp 2010). Kuo et al. (2006) showed
that in mice and rats CTR1 expression is regulated by
copper status (Bauerly et al. 2005; Kuo et al. 2006). In
the present study we found that Ctr1 gene expression
matched these patterns. We also found that in neonatal
rats after birth Ctr1 expression in the liver is rather low
and gradually increased. There was no apparent effect
of iron deficiency on expression of the Ctr1 gene at
any stage in gestation.
Following uptake across the cell membrane, copper
is bound to one of a class of proteins called metallo-
chaperones. Several have been identified, each of
which will deliver copper from the membrane to a
particular target protein. These targets are shown in
Fig. 1.
Anti-oxidant 1 protein (ATOX1) (Klomp et al.
1997), transports Cu to ATP7A and ATP7B, the Cu-
transport ATPases (Lutsenko et al. 2007, 2008; Van
den Berghe and Klomp 2010). In adult liver, ATP7A
expression is extremely low (Lenartowicz et al. 2010).
However, in the fetus and neonate, both ATPases are
expressed. Interestingly, expression levels of Atp7a,
but not Atp7b, and Atox1 are inversely proportional.
Why this should be is not clear, but it could be related
to either regulation of Atp7a by ATOX1, or possibly to
the transcription factor function of ATOX1. Itoh and
co-workers showed that copper promotes transport of
ATOX1 protein to the nucleus where it is bound to the
promoter of regulated genes resulting in up-regulation
of Cycline D1, (Ccnd 1), and extracellular SOD
(SOD3) genes (Itoh et al. 2008, 2009).
In hepatocytes, ATP7B protein is localized in the
trans-Golgi network (Schaefer et al. 1999; Bingham
et al. 1996) where it is involved in the process of Cu
binding to apo-ceruloplasmin (Lutsenko et al. 2007;
Terada et al. 1998). It also transfers copper from the
hepatocyte to the bile in the case of copper excess
(Bauerly et al. 2005; Roelofsen et al. 2000; Huster
et al. 2006; Wijmenga and Klomp 2004). In the fetus,
the bile duct is not patent, and copper accumulates in
the liver (Guo et al. 2005; Lutsenko et al. 2003; La
Fontaine and Mercer 2007; Mercer et al. 2003;
Schaefer et al. 1999), although it may also be that
the copper is accumulated in order to provide a store
for the perinatal period.
This is the first study to compare Atp7b and Atp7a
expression levels in the liver of fetal and neonatal
animals. Previous work from our laboratories showed
developmental regulation of Atp7a expression in the
liver of neonatal mice (Lenartowicz et al. 2010, 2011)
but little is known about expression pattern of Atp7b in
the liver. Here, we show that in the liver of the
neonatal rats Atp7a expression dropped in the perina-
tal period, but then stabilised, while Atp7b expression
remained low. The data suggest that, in the liver of
very young animals, Atp7a/ATP7A plays the domi-
nant role in regulation of copper metabolism. By
adulthood, this is reversed, and Atp7b/ATP7B is the
only transporter. Alternatively, the data could reflect
the relatively important role the fetal and neonatal
liver plays in haematopoiesis, and the high concen-
tration of haematopoietic cells in the liver.
Ceruloplasmin is a ferroxidase, containing 6 Cu
atoms per molecule protein, and is required for
oxidation of Fe2? to Fe3? and thus for iron efflux
from the cells via ferroportin. Ceruloplasmin is also
the major plasma copper binding protein (Tran et al.
2002; Hellman and Gitlin 2002; Broderius et al.
2010; Prohaska 2011). Incorporation of copper to
the ceruloplasmin is mediated by ATP7B protein
56 Biometals (2015) 28:51–59
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(Terada et al. 1998). During development, ceruloplas-
min expression starts very early (Fleming and Gitlin
1990; Lee et al. 1993) and mRNA in the liver was
detected at E15. Expression increases between 17th
and 20th day of gestation and drops just before
delivery (Fleming and Gitlin 1990). Such findings
closely overlap with our own results. Terao and Owen
(1977) reported that ceruloplasmin protein levels in
the liver of rat pups increase sharply in the first 24 h
after birth, which also fits with our data. Ceruloplas-
min gene expression unexpectedly significantly
decreased at Day 3. In rats in the 3th day postpartum
copper levels in the mother’s milk are highest and drop
thereafter (Terao and Owen 1977). We speculate that
decreasing ceruloplasmin synthesis at this stage may
protect the neonates against excess copper. As copper
in the milk decreases thereafter, Cp levels rise again.
Both in vitro experiments on isolated hepatocytes
(McArdle et al. 1990) and in vivo studies on mice and
rats indicated that copper deficiency have no impact on
ceruloplasmin mRNA in the liver (Prohaska 2011;
Mercer et al. 1991; Mostad and Prohaska 2011) and
our current data also show no difference between
control and Fe deficient livers.
Copper, zinc superoxide dismutase (SOD1) pro-
tects cells against reactive oxygen species that are
generated during the processes of oxidative metabo-
lism. Activity of SOD1 is closely dependent on its
copper chaperone, CCS, which is necessary for
insertion of Cu ions to apo-SOD1 (Wong et al.
2000). Copper supplementation results in decreasing
of CCS and SOD1 mRNA level both in the liver and
peripheral mononuclear blood cells (Suazo et al. 2008;
Han et al. 2009). Here, we found a significant decrease
in CCS expression, which may also be caused by the
increase in Cu levels. It is known that in pups born
from Fe deficient mothers copper concentration in the
liver is significantly increased (Sherman and Moran
1984; Sherman and Tissue 1981). In both investigated
group of rats CCS mRNA level rapidly and signifi-
cantly increased during first 24 h of postnatal life.
Cytochrome c oxidase is a terminal complex in the
respiratory chain (Oswald et al. 2009; Voronova et al.
2007). Uptake, transport and delivery of the copper
ions to the enzyme are complicated processes; requir-
ing activity at least six copper chaperones (Voronova
et al. 2007). One of these is COX 17, a small
hydrophobic protein which contains copper binding
domains, binds and transports copper ions in the
cytoplasm and also participates in shuttling Cu ions
through the mitochondrial membrane to the inter-
membrane mitochondrial space (Oswald et al. 2009;
Voronova et al. 2007; Kako et al. 2004; Punter and
Glerum 2003). In rats Cox 17 expression in the brain
and heart was detected in prenatal life and it was
shown that the expression profile was age- and tissue-
dependent and changes during development (Kako
et al. 2000). In the present study we analysed
expression of the Cox 17 in the liver of the fetus and
neonatal rats and found similar results. In the iron
deficient animals after birth, Cox17 expression was
higher than control. This may be related to different
nutritional profiles in the iron-deficinet dams, but may
also be a consequence of reduced mitochondrial
function in the iron deficient animals.
In summary, the data presented show that, while
there are marked changes in the expression of the
genes of copper metabolism while development
proceeds, the consequences of iron deficiency are
limited and cannot explain the increasing copper
levels in the iron deficient liver.
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